title: Adenosine diphosphate-decorated chitosan nanoparticles shorten blood clotting times, influencing the structures and varying the mechanical properties of the clots.
abstract: Chitosan nanoparticles (NPs) decorated with adenosine diphosphate (ADP) (ANPs) or fibrinogen (FNPs) were used to fabricate hemostatic NPs that can shorten blood clotting time and prevent severe local hemorrhage. The structure and mechanical properties of the blood clot induced with ANP (clot/ANP) or FNP (clot/FNP) were also investigated. The NPs, ANPs, and FNPs, which had particle sizes of 245.1 ± 14.0, 251.0 ± 9.8, and 326.5 ± 14.5 nm and zeta potentials of 24.1 ± 0.5, 20.6 ± 1.9, and 15.3 ± 1.5 mV (n=4), respectively, were fabricated by ionic gelation and then decorated with ADP and fibrinogen. The zeta potentials and Fourier transform infrared (FTIR) spectroscopy of the NPs confirmed that their surfaces were successfully coated with ADP and fibrinogen. The scanning electron microscope (SEM) micrographs of the structure of the clot induced with "undecorated" chitosan NPs (clot/NP), clot/ANP, and clot/FNP (at 0.05 wt%) were different, after citrated bloods had been recalcified by a calcium chloride solution containing NPs, ANPs, or FNPs. This indicated that many NPs adhered on the membrane surfaces of red blood cells, that ANPs induced many platelet aggregates, and that FNPs were incorporated into the fibrin network in the clots. Measurements of the blood clotting times (Tc) of blood clot/NPs, clot/ANPs, and clot/FNPs, based on 90% of ultimate frequency shifts measured on a quartz crystal microbalance (QCM), were significantly (P<0.05) (n=4) shorter than that of a clot induced by a phosphate-buffered solution (PBS) (clot/PBS) (63.6% ± 3.1%, 48.3% ± 6.2%, and 63.2% ± 4.7%, respectively). The ΔF2 values in the spectra of frequency shifts associated with the propagation of fibrin networks in the clot/ANPs and clot/FNPs were significantly lower than those of clot/PBS. Interestingly, texture profile analysis of the compressional properties showed significantly lower hardness and compressibility in clot/NPs and clot/ANPs (P<0.05 or better) (n=4) compared with clot/PBS and clot/FNPs. Accordingly, among the hemostatic NPs, ANP substantially reduced blood clotting times, ΔF2 values, and compression flow properties of the clot. Hence, ANPs have potential applications for preventing severe local hemorrhage.
authors.affiliation: Department of Biomedical Engineering, National Yang-Ming University, Taipei, Taiwan, Republic of China ; Department of Chemical and Materials Engineering, National Yunlin University of Science and Technology, Yunlin, Taiwan, Republic of China.
authors.forename: Tze-Wen
authors.initials: TW
authors.lastname: Chung
authors.affiliation: Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
authors.forename: Pei-Yi
authors.initials: PY
authors.lastname: Lin
authors.affiliation: Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
authors.forename: Shoei-Shen
authors.initials: SS
authors.lastname: Wang
authors.affiliation: Department of Chemical and Materials Engineering, National Yunlin University of Science and Technology, Yunlin, Taiwan, Republic of China.
authors.forename: Yen-Fung
authors.initials: YF
authors.lastname: Chen
mesh_terms: D000244:Adenosine Diphosphate / Q000008:administration & dosage* / Q000737:chemistry; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology*; D001780:Blood Coagulation Tests / Q000379:methods; D048271:Chitosan / Q000008:administration & dosage* / Q000737:chemistry; D019245:Compressive Strength / Q000187:drug effects / Q000502:physiology; D004338:Drug Combinations; D006244:Hardness / Q000187:drug effects / Q000502:physiology; D006490:Hemostatics / Q000008:administration & dosage / Q000138:chemical synthesis; D006801:Humans; D053769:Nanocapsules / Q000008:administration & dosage* / Q000737:chemistry
chemical_list: D004338:Drug Combinations; D006490:Hemostatics; D053769:Nanocapsules; D000244:Adenosine Diphosphate; D048271:Chitosan
keywords: ADP; compressional properties; fibrinogen; hemostatic NPs
references.citation: Biomaterials. 2012 May;33(15):3909-18
references.pmid: 22374455
references.citation: Biomaterials. 2010 Oct;31(30):7620-30
references.pmid: 20656346
references.citation: J Biomed Mater Res. 2002 Jun 5;60(3):348-59
references.pmid: 11920657
references.citation: Biomaterials. 2011 Oct;32(28):6655-62
references.pmid: 21676458
references.citation: Acad Emerg Med. 2008 Jan;15(1):74-81
references.pmid: 18211317
references.citation: Biosens Bioelectron. 1998 Feb 1;13(2):147-56
references.pmid: 9597731
references.citation: Biomaterials. 2010 Aug;31(22):5749-58
references.pmid: 20435346
references.citation: Biomacromolecules. 2009 Sep 14;10(9):2427-35
references.pmid: 19642670
references.citation: Biomaterials. 2009 Sep;30(27):4447-56
references.pmid: 19535136
references.citation: J Biomed Mater Res A. 2009 Dec;91(3):753-61
references.pmid: 19051299
references.citation: J Trauma. 2008 Apr;64(4):1093-9
references.pmid: 18404080
references.citation: Carbohydr Polym. 2013 Jan 30;92(1):591-7
references.pmid: 23218340
references.citation: J Trauma. 2007 Aug;63(2):276-83; discussion 283-4
references.pmid: 17693824
references.citation: Biomaterials. 2009 Aug;30(22):3757-65
references.pmid: 19410289
references.citation: Biomaterials. 2008 Jan;29(2):228-37
references.pmid: 17953984
references.citation: Biomaterials. 2012 Apr;33(11):3306-15
references.pmid: 22281422
references.citation: Thromb Haemost. 2005 May;93(5):880-8
references.pmid: 15886804
references.citation: J Pharm Sci. 1999 Jun;88(6):592-8
references.pmid: 10350494
references.citation: Analyst. 2012 Nov 7;137(21):4921-33
references.pmid: 22910856
references.citation: AAPS PharmSciTech. 2010 Mar;11(1):181-8
references.pmid: 20101482
references.citation: Biomaterials. 2010 Feb;31(6):1270-7
references.pmid: 19880175
references.citation: Anal Chem. 2010 Jan 15;82(2):658-63
references.pmid: 20000697
references.citation: J Trauma. 2006 Dec;61(6):1312-20
references.pmid: 17159671
references.citation: Br J Surg. 2008 Oct;95(10):1197-225
references.pmid: 18763249
references.citation: J Am Chem Soc. 2003 Jun 25;125(25):7494-5
references.pmid: 12812471